ArticleFrontiers in pharmacology2024

PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced ColitiS.

Daifang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.